tiprankstipranks
Pharma Mar SA (ES:PHM)
BME:PHM
Spanish Market

Pharma Mar SA (PHM) Income Statement

Compare
11 Followers

Pharma Mar SA Income Statement

Last quarter (Q3 2024), Pharma Mar SA's total revenue was €45.66M, an increase of 21.90% from the same quarter last year. In Q3, Pharma Mar SA's net income was €3.90M. See Pharma Mar SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
€ 158.15M€ 196.34M€ 229.83M€ 269.96M€ 85.82M
Gross Profit
€ 148.54M€ 182.70M€ 213.39M€ 256.24M€ 80.59M
Operating Expenses
€ 152.37M€ 138.27M€ 121.04M€ 100.03M€ 98.07M
Depreciation and Amortization
€ 5.76M€ 5.90M€ 5.58M€ 7.21M€ 6.05M
EBITDA
€ 4.55M€ 52.07M€ 104.08M€ 155.94M€ -11.71M
Operating Income
€ -3.83M€ 44.07M€ 92.45M€ 155.94M€ -17.48M
Other Income/Expenses
€ 204.00K€ -281.00K€ -6.36M€ -10.34M€ -4.17M
Pretax Income
€ -3.62M€ 43.79M€ 95.13M€ 145.61M€ -21.65M
Net Income
€ 1.14M€ 49.36M€ 92.86M€ 137.26M€ -9.18M
Per Share Metrics
€ ―€ ―€ ―€ ―€ ―
Basic EPS
€ 0.06€ 2.73€ 5.14€ 7.50€ -0.50
Diluted EPS
€ 0.06€ 2.73€ 5.13€ 7.49€ -0.50
Weighted Average Shares Outstanding
17.90M 18.05M 18.07M 18.29M 18.44M
Weighted Average Shares Outstanding (Diluted)
17.92M 18.06M 18.09M 18.32M 18.44M
Currency in EUR

Pharma Mar SA Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis